EXCITING ANNOUNCEMENT (1920 x 1080 px) (1920 x 600 px) (1920 x 400 px)

ProofPilot + Lokavant: Transforming Clinical Trials Together

We’re excited to announce that ProofPilot has acquired Lokavant, the clinical trial intelligence company known for its predictive analytics platform.

By combining ProofPilot’s end-to-end trial execution platform with Lokavant’s advanced analytics, we’re creating something new: a single, integrated solution that helps sponsors and research organizations design smarter studies, anticipate challenges, and deliver therapies to patients faster.

Why this matters

Lokavant’s technology—spun out of Roivant in 2020—uses historical and real-time data to generate predictive insights. Integrated into ProofPilot, these capabilities will enable:

  • Smarter planning: optimize feasibility and resource allocation.

  • Real-time foresight: anticipate risks before they impact a study.

  • Better outcomes: reduce operational surprises and accelerate timelines.

A shared vision

ProofPilot has always been about giving sponsors and research teams the tools they need to run better trials,” said Chris Venezia, CEO of ProofPilot. “With Lokavant’s predictive analytics, our customers can now measure and forecast success in real time—something the industry has never had before.”

Lokavant’s co-founder and CEO, Rohit Nambisan, added: “Together, we’re giving CROs and sponsors unprecedented clarity into study performance. This is about planning smarter, adapting faster, and ultimately bringing new therapies to patients more efficiently.”

What this means for you

The combined platform introduces a new standard for trial management:

  • AI-powered forecasting to support proactive scenario planning.

  • Recruitment and performance dashboards to monitor progress in real time.

  • Study oversight tools that strengthen compliance and data quality.

The result: greater predictability, lower risk, and more reliable trials—so that innovative therapies reach patients sooner.

Looking ahead

This acquisition marks a transformative moment for ProofPilot and our customers. By uniting digital trial execution with predictive intelligence, we’re delivering a comprehensive solution that raises the bar for how clinical research is planned and run.

Want to learn more? Get in touch with our team or read the full announcement

iStock
A-LIGN_SOC-2 Logo
image 10
image 8
attachment (3) 1
image 7
Group 3a02